Centre for Policy on Ageing
 

 

Placebo-controlled treatment trial of depression in elderly physically ill patients
Author(s)M Evans, M Hammond, K Wilson
Journal titleInternational Journal of Geriatric Psychiatry, vol 12, no 8, August 1997
Pagespp 817-824
KeywordsDepression ; Ill health ; Drugs ; Clinical surveys ; Liverpool.
AnnotationAcute geriatric medical inpatients with depression at the Royal Liverpool University Hospital were randomly assigned to an 8-week double-blind placebo-controlled trial of fluoxetine, and their response to the treatment was measured by the 17-item Hamilton Depression Rating Scale (HAMD). 82 patients entered the trial; 62 patients (all those who had completed at least 3 weeks of treatments) were included in the efficacy analysis. 42 completed the full 8 weeks (21 in each group) with response rates of 67% in the fluoxetine group and 38% in the placebo group. There was no significant difference in the responses of the two groups. There was a trend for results in the fluoxetine group to continue to improve with time. On secondary analysis, the 37 patients with serious physical illness who completed 5 or more weeks showed a significant improvement in mood if treated with fluoxetine. The main benefit of antidepressants is to approximately double the chances of recovery. The presence of physical illness, often severe and/or multiple did not reduce the effectiveness of the medication. The trial demonstrated that those with serious physical disease responded significantly better to drug treatment, though this requires more research. (RH).
Accession NumberCPA-980827253 A
ClassmarkENR: CH: LLD: 3G: 84B

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk